Trust Company of the South’s Amgen AMGN Stock Holding History

Trust Company of the South’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$386K	Hold	1,065	–	–	0.05%	102
2026 Q1	$375K	Hold	1,065	–	–	0.06%	102
2025 Q4	$349K	Sell	1,065 -225	-17%	-$71.4K	0.06%	99
2025 Q3	$364K	Buy	1,290 +474	+58%	+$137K	0.06%	100
2025 Q2	$228K	Sell	816 -17	-2%	-$4.82K	0.04%	114
2025 Q1	$260K	Buy	+833	New	+$246K	0.05%	108

Other funds holding AMGN

Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Trust Company of the South's AMGN Position: Q2 2026 in Review

Trust Company of the South held its Amgen (AMGN) position steady in Q2 2026 at 1,065 shares worth $386K. The position accounts for 0.05% of the portfolio, ranked #102.

Trust Company of the South first reported a position in AMGN in Q1 2025 and has held it in 6 quarters since. 1,665 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Trust Company of the South held 1,065 shares of Amgen worth $386K as of Q2 2026.
Trust Company of the South left its Amgen share count unchanged in Q2 2026.
Amgen made up 0.05% of Trust Company of the South's portfolio in Q2 2026, its #102 holding.
Trust Company of the South first reported a position in Amgen in Q1 2025 and has held it in 6 quarters since.
1,665 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Trust Company of the South's 13F filing for Q2 2026, filed 1 Jul 2026.